[ad_1]
“In my opinion, now we can say this, it is clear that there is a link with this vaccine,” although it is not yet clear what causes this reaction, Cavaleri told Il Messaggero.
It is true that the EEA later reported “pending a conclusion” and emphasized that “the assessment is still ongoing”.
Amsterdam-based EVA held a virtual press conference on Wednesday night in which agency director Emer Cooke and other senior officials presented their findings on a possible link between the AstraZeneca pandemic coronavirus vaccine and clots. of blood.
According to Marie-Agnes Heine, Director of the EEA Communication Department, the Agency’s Safety Committee has investigated rare cases of blood clots in people vaccinated with Vaxzevria in many European Union (EU) countries. It was concluded that unusual blood clots could be considered as a possible side effect of Vaxzevria and should be reported.
AstraZeneca vaccine for coronavirus
Cooke said the EVA had decided, after extensive investigation, that rare cases of blood clots in people who had been vaccinated with AstraZeneca should be included in the list of possible side effects of the vaccine.
“The EEA Safety Committee concluded today that abnormal blood clots with a low platelet count should be identified as a very rare side effect,” the Amsterdam-based agency said in a statement.
Cooke added: “Based on the available evidence, specific risk factors such as age, sex or blood clotting disorders are not directly related to this.” This risk factor does not depend on age, sex, or pre-existing conditions. However, this vaccine is not recommended for people under the age of 30 in the UK. People ages 18 to 29 are offered other vaccinations, the BBC reports.
Despite a British warning, the EVA did not impose new restrictions on the use of the vaccine in people over 18 in a statement issued Wednesday.
According to the EVA, most bleeding disorders occurred in women under the age of 60 during the first two weeks after vaccination. Based on currently available data, specific risk factors could not be confirmed, the agency said.
„The likely explanation for these rare side effects is an immune response to the vaccine, ”Cooke said. This conclusion is reached in view of the fact that the same side effects sometimes occur in patients treated with „Heparin“Medicines.
At the same time, Cooke said that the EEA Safety Committee had confirmed that AstraZeneca’s benefits in protecting against COVID-19 outweigh the risks of potential side effects.
AstraZeneca vaccine for coronavirus
“COVID-19 is a very serious disease causing high numbers of hospitalizations and thousands of deaths across the EU. The vaccine has been shown to be highly effective in reducing hospitalizations and saving lives.” – E. Cooke noted.
The conference takes place after several European countries stopped vaccinating the drug due to its possible link to blood clotting problems.
The Agency has so far stated that AstraZeneca is safe and effective, and that its benefits in preventing serious illness and death clearly outweigh the potential risks.
Last week, following a meeting of an expert committee, the EEA said it had examined known cases of blood clots without identifying “any specific risk factors” such as age, sex or previous health.
The experts reviewed several dozen cases recorded in Europe and the United Kingdom, where around 25 million people have been vaccinated with AstraZeneca. persons.
It is strictly forbidden to use the information published by DELFI on other websites, in the media or elsewhere, or to distribute our material in any way without consent, and if consent has been obtained, it is necessary to indicate DELFI as the source.
[ad_2]
